Medline Expands AI Platform and Warehouse Robotics

Why It Matters

The rollout strengthens Medline’s position as a resilient, technology‑enabled supply‑chain partner, helping hospitals cut costs and mitigate shortages amid tightening reimbursement and policy pressures.

Key Takeaways

• Mpower AI platform to act as supply‑chain control tower
• AutoStore robots now in 19 U.S. Medline facilities
• Symbotic bulk‑picking pilot marks first healthcare deployment
• $2.4 B new contracts drive 2025 sales surge
• Expected 8‑9% organic growth in 2026 from automation

Pulse Analysis

Medline’s acceleration of artificial intelligence reflects a broader shift in healthcare logistics, where predictive analytics and real‑time visibility are becoming essential. By integrating Microsoft’s AI capabilities into the Mpower platform, Medline offers hospitals a single “control tower” that can anticipate demand spikes, suggest product substitutions, and flag potential supply disruptions before they materialize. This level of automation not only reduces manual planning effort but also aligns with hospitals’ growing need for resilient, data‑driven supply chains amid volatile reimbursement models.

At the distribution‑center level, Medline’s deployment of AutoStore’s goods‑to‑person robots across 19 sites demonstrates a commitment to speed and accuracy in order fulfillment. The system’s 2,100+ robots enable rapid picking of individual items, cutting errors and shortening delivery windows. The new partnership with Symbotic introduces AI‑powered bulk‑picking for high‑volume SKUs, marking the first such deployment in the health‑care sector. Together, these technologies aim to boost throughput, alleviate labor shortages, and maximize existing warehouse footprints without costly expansion.

Financially, the technology push underpins Medline’s robust top‑line growth—sales rose 11.5% to $28.4 billion in 2025, driven by $2.4 billion in fresh contracts including the U.S. Department of Veterans Affairs. While earnings dipped due to higher investment costs, the company expects 8‑9% organic sales growth in 2026 as automation delivers cost efficiencies and supports new business wins. Medline’s strategy positions it as a leading, tech‑forward distributor in a market where AI and robotics are rapidly becoming differentiators for supply‑chain resilience and profitability.